[Microvascular changes in COVID-19].
Mikrovaskuläre Veränderungen bei COVID-19.
Computed tomography
Microvessels
Pathological correlation
Perfusion
SARS-CoV‑2
Journal
Der Radiologe
ISSN: 1432-2102
Titre abrégé: Radiologe
Pays: Germany
ID NLM: 0401257
Informations de publication
Date de publication:
Oct 2020
Oct 2020
Historique:
pubmed:
29
8
2020
medline:
8
10
2020
entrez:
29
8
2020
Statut:
ppublish
Résumé
Clinically, coronavirus disease 2019 (COVID-19) is associated with a wide range of symptoms, which can range from mild complaints of an upper respiratory infection to life-threatening hypoxic respiratory insufficiency and multiorgan failure. The initially identified pulmonary damage patterns, such as diffuse alveolar damage in acute lung failure, are accompanied by new findings that draw a more complex scenario. These include microvascular involvement and a wide range of associated pathologies of multiple organ systems. A back-scaling of microstructural vascular changes is possible via targeted correlation of pathological autopsy results with radiological imaging. Radiological and pathological correlation as well as microradiological imaging to investigate microvascular involvement in fatal COVID-19. The cases of two COVID-19 patients are presented. Patient 1 showed a relative hypoperfusion in lung regions that did not have typical COVID-19 infiltrates; the targeted post-mortem correlation also showed subtle signs of microvascular damage even in these lung sections. Patient 2 showed both radiologically and pathologically advanced typical COVID-19 destruction of lung structures and the case illustrates the damage patterns of the blood-air barrier. The perfusion deficit of the intestinal wall shown in computed tomography of patient 2 could not ultimately clearly be microscopically attributed to intestinal microvascular damage. In addition to microvascular thrombosis, our results indicate a functional pulmonary vasodysregulation as part of the pathophysiology during the vascular phase of COVID-19. The clinical relevance of autopsies and the integration of radiological imaging findings into histopathological injury patterns must be emphasized for a better understanding of COVID-19.
Sections du résumé
BACKGROUND
BACKGROUND
Clinically, coronavirus disease 2019 (COVID-19) is associated with a wide range of symptoms, which can range from mild complaints of an upper respiratory infection to life-threatening hypoxic respiratory insufficiency and multiorgan failure.
OBJECTIVE
OBJECTIVE
The initially identified pulmonary damage patterns, such as diffuse alveolar damage in acute lung failure, are accompanied by new findings that draw a more complex scenario. These include microvascular involvement and a wide range of associated pathologies of multiple organ systems. A back-scaling of microstructural vascular changes is possible via targeted correlation of pathological autopsy results with radiological imaging.
MATERIAL AND METHODS
METHODS
Radiological and pathological correlation as well as microradiological imaging to investigate microvascular involvement in fatal COVID-19.
RESULTS
RESULTS
The cases of two COVID-19 patients are presented. Patient 1 showed a relative hypoperfusion in lung regions that did not have typical COVID-19 infiltrates; the targeted post-mortem correlation also showed subtle signs of microvascular damage even in these lung sections. Patient 2 showed both radiologically and pathologically advanced typical COVID-19 destruction of lung structures and the case illustrates the damage patterns of the blood-air barrier. The perfusion deficit of the intestinal wall shown in computed tomography of patient 2 could not ultimately clearly be microscopically attributed to intestinal microvascular damage.
CONCLUSION
CONCLUSIONS
In addition to microvascular thrombosis, our results indicate a functional pulmonary vasodysregulation as part of the pathophysiology during the vascular phase of COVID-19. The clinical relevance of autopsies and the integration of radiological imaging findings into histopathological injury patterns must be emphasized for a better understanding of COVID-19.
Identifiants
pubmed: 32857175
doi: 10.1007/s00117-020-00743-w
pii: 10.1007/s00117-020-00743-w
pmc: PMC7453182
doi:
Types de publication
Journal Article
Review
Langues
ger
Sous-ensembles de citation
IM
Pagination
934-942Références
Am J Respir Crit Care Med. 2020 May 15;201(10):1299-1300
pubmed: 32228035
JAMA. 2020 Aug 25;324(8):782-793
pubmed: 32648899
Cardiovasc Res. 2020 May 1;116(6):1097-1100
pubmed: 32227090
Radiology. 2020 Jul;296(1):172-180
pubmed: 32255413
N Engl J Med. 2020 Jul 9;383(2):120-128
pubmed: 32437596
Dtsch Arztebl Int. 2020 Jul 20;117(29-30):500-506
pubmed: 32865490
Cell. 2020 May 28;181(5):1016-1035.e19
pubmed: 32413319
Intensive Care Med. 2020 Jun;46(6):1099-1102
pubmed: 32291463
J Pathol. 2004 Jun;203(2):631-7
pubmed: 15141377
J Pathol Clin Res. 2019 Apr;5(2):108-114
pubmed: 30697960
Lancet Infect Dis. 2020 Dec;20(12):1365-1366
pubmed: 32359410
Radiology. 2017 Apr;283(1):252-263
pubmed: 27715655
Intensive Care Med. 2020 Sep;46(9):1777-1778
pubmed: 32533198
Thromb Res. 2020 Jul;191:145-147
pubmed: 32291094